Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

François Lemonnier; Elsa Poullot; Aurélie Dupuy; Lucile Couronné; Nadine Martin; Laurianne Scourzic; Virginie Fataccioli; Julie Bruneau; Rob A. Cairns; Tak W. Mak; Olivier A. Bernard; Laurence de Leval; Philippe Gaulard

doi:10.3324/haematol.2017.167973

Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

François Lemonnier, Elsa Poullot, Aurélie Dupuy, Lucile Couronné, Nadine Martin, Laurianne Scourzic, Virginie Fataccioli, Julie Bruneau, Rob A. Cairns, Tak W. Mak, Olivier A. Bernard, Laurence de Leval, Philippe Gaulard

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

25 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	e115-e118
journal	Haematologica
Volume	103
Numéro de publication	3
Les DOIs	https://doi.org/10.3324/haematol.2017.167973
état	Publié - 28 févr. 2018

Accès au document

10.3324/haematol.2017.167973

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{e6707c7aa3484a27b8e6cdc3de063412,

title = "Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas",

author = "Fran{\c c}ois Lemonnier and Elsa Poullot and Aur{\'e}lie Dupuy and Lucile Couronn{\'e} and Nadine Martin and Laurianne Scourzic and Virginie Fataccioli and Julie Bruneau and Cairns, {Rob A.} and Mak, {Tak W.} and Bernard, {Olivier A.} and {de Leval}, Laurence and Philippe Gaulard",

note = "Funding Information: 1INSERMU955 {\'e}quipe 9, Institut Mondor de Recherche Biom{\'e}dicale, Cr{\'e}teil, France;2Universit{\'e} Paris-Est, Facult{\'e} de M{\'e}decine, Cr{\'e}teil, France;3D{\'e}partement de Pathologie, Groupe Henri-Mondor Albert-Chenevier, AP-HP, Cr{\'e}teil, France;4INSERMU1170, Institut Gustave Roussy, Universit{\'e} Paris-Sud, Villejuif, France; 5D{\'e}partement de Pathologie, H{\^o}pital Necker Enfants Malades, APHP, Paris, France;6Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, Toronto, Canada and 7Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland *These authors contributed equally to this paper Acknowledgments: the authors thank all members of the TENOM-IC program. FL received a grant from the Institut National du Cancer (INCa). Funding: this study was supported by a grant from the Association pour la Recherche contre le Cancer (ARC), the grant N. DEQ20160334875 “Equipe FRM 2016” from Fondation pour la Recherche M{\'e}dicale and the Leukemia Lymphoma Society (LLS). Correspondence: [email protected] doi:10.3324/haematol.2017.167973 Information on authorship, contributions, and financial & other disclo- sures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2018",

month = feb,

day = "28",

doi = "10.3324/haematol.2017.167973",

language = "English",

volume = "103",

pages = "e115--e118",

journal = "Haematologica",

issn = "0390-6078",

number = "3",

}

TY - JOUR

T1 - Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

AU - Lemonnier, François

AU - Poullot, Elsa

AU - Dupuy, Aurélie

AU - Couronné, Lucile

AU - Martin, Nadine

AU - Scourzic, Laurianne

AU - Fataccioli, Virginie

AU - Bruneau, Julie

AU - Cairns, Rob A.

AU - Mak, Tak W.

AU - Bernard, Olivier A.

AU - de Leval, Laurence

AU - Gaulard, Philippe

N1 - Funding Information: 1INSERMU955 équipe 9, Institut Mondor de Recherche Biomédicale, Créteil, France;2Université Paris-Est, Faculté de Médecine, Créteil, France;3Département de Pathologie, Groupe Henri-Mondor Albert-Chenevier, AP-HP, Créteil, France;4INSERMU1170, Institut Gustave Roussy, Université Paris-Sud, Villejuif, France; 5Département de Pathologie, Hôpital Necker Enfants Malades, APHP, Paris, France;6Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, Toronto, Canada and 7Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland *These authors contributed equally to this paper Acknowledgments: the authors thank all members of the TENOM-IC program. FL received a grant from the Institut National du Cancer (INCa). Funding: this study was supported by a grant from the Association pour la Recherche contre le Cancer (ARC), the grant N. DEQ20160334875 “Equipe FRM 2016” from Fondation pour la Recherche Médicale and the Leukemia Lymphoma Society (LLS). Correspondence: [email protected] doi:10.3324/haematol.2017.167973 Information on authorship, contributions, and financial & other disclo- sures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042783719&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.167973

DO - 10.3324/haematol.2017.167973

M3 - Letter

C2 - 29242297

AN - SCOPUS:85042783719

SN - 0390-6078

VL - 103

SP - e115-e118

JO - Haematologica

JF - Haematologica

IS - 3

ER -